Zarmina Javed
Neurology · Coral Springs, FLNPI 1861001570
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $753, more than ten times the $15 reported in 2021. That places this record below the midpoint for neurology clinicians in FL, where the typical reported total is $1,698.
Across 80 payments — averaging $25.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$334
- Biogen$246
- Takeda Pharmaceuticals U.S.A., Inc.$212
- Merz Pharmaceuticals, LLC$129
- AstraZeneca$123
- Novartis$113
- plus $898 from 20 others
What the payments were for
- Food & beverage$2,055100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $334 |
| Biogen | 7 | $246 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $212 |
| Merz Pharmaceuticals, LLC | 2 | $129 |
| AstraZeneca | 6 | $123 |
| Novartis | 6 | $113 |
| Biocodex, Inc. | 3 | $104 |
| Genentech, Inc. | 2 | $95 |
| EMD Serono, Inc. | 4 | $85 |
| Amgen | 2 | $62 |
| Sanofi | 2 | $59 |
| Argenx US, Inc. | 2 | $56 |
| Medtronic | 2 | $55 |
| TG Therapeutics, Inc. | 2 | $54 |
| Jazz Pharmaceuticals Inc. | 2 | $46 |
| Janssen Scientific Affairs, LLC | 1 | $42 |
| Neurocrine Biosciences, Inc. | 2 | $35 |
| Neurelis, Inc. | 2 | $34 |
| Genentech USA, Inc. | 1 | $24 |
| Catalyst Pharmaceuticals, Inc. | 1 | $24 |
| Acadia Pharmaceuticals Inc | 1 | $23 |
| Novo Nordisk | 1 | $21 |
| Eisai Inc. | 1 | $21 |
| Immedica Pharma US, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Acorda Therapeutics, Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,055 in reported general payments places this provider in the 50th percentile of 1,434 neurology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 12 | $166 |
Paid to pharmacies, not to this prescriber.
Other neurology in Coral Springs
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Matthew BakerNaples$1.4M
- Donald NegroskiSarasota$1.4M
- Mark CascioneTampa$1.2M
- Lance KimOcala$1M
- Tuan VuTampa$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.